A tumor-associated antigen expressed in melanoma cells with lower malignant potential
- 15 June 1985
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 35 (6) , 787-791
- https://doi.org/10.1002/ijc.2910350615
Abstract
The antigen K-1-2, detectable by a MAb is found in nevi and melanomas. It is associated with melanoma cells of low invasive and metastatic potential as shown by immunoperoxidase studies with cell lines, biopsies and autopsies: K-1-2 occurs in melanoma cell line SK-Mel 25, but not in cell line A-375. A-375 has a higher malignant potential than SK-Mel 25 because, in contrast to SK-Mel 25, it produces plasminogen activator and grows in nude mice. K-1-2 was frequently strongly expressed (≥ 50% cells positive) in flat (< 1.5 mm) and less frequently in medium and thick primary tumors. In thick primary melanomas K-1-2 positive cells were confined to the junctional zone or to marginal, flat areas of the tumor. Only rarely does K-1-2 occur in metastases. Strong expression of the K-1-2 antigen was found less often in primary melanomas, which develop early metastases, than in tumors that had not metastasized during an observation period of 18 months. In 5 patients with disseminated metastatic disease, metastases strongly expressing K-1-2 and those negative for this marker or containing only a minor percentage of K-1-2 positive cells were observed simultaneously or at different times. These findings suggest that a change from high malignancy to low malignancy—as observed in animal systems—may also occur in human melanoma.This publication has 17 references indexed in Scilit:
- Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.The Journal of Experimental Medicine, 1984
- HLA-DR Antigen Expression in Primary Melanomas of the SkinJournal of Investigative Dermatology, 1984
- Comparative Analysis of Melanoma-Associated Antigens in Primary and Metastatic Tumour TissuePublished by S. Karger AG ,1984
- The impact of monoclonal antibodies on the study of human malignant melanomaJournal of Cutaneous Pathology, 1983
- Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodiesCancer Immunology, Immunotherapy, 1983
- Expression of Thy‐1 antigen on human melanoma cellsInternational Journal of Cancer, 1983
- Cell-Surface Structure and State of Malignancy in Human Malignant MelanomaPublished by Springer Nature ,1982
- Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.The Journal of Experimental Medicine, 1981
- The pathogenesis of cancer metastasisNature, 1980
- Organ specificity of blood-borne tumour metastasis determined by cell adhesion?Nature, 1975